BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37171351)

  • 1. Longitudinal follow-up of pediatric Graves' disease in preschool children: Clinical characteristics and a case report.
    Yang JW; Kao LY; Chuang LH; Chen HM
    Medicine (Baltimore); 2023 May; 102(19):e33680. PubMed ID: 37171351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Graves' ophthalmopathy: the pre- and postpubertal experience.
    Holt H; Hunter DG; Smith J; Dagi LR
    J AAPOS; 2008 Aug; 12(4):357-60. PubMed ID: 18359653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compressive optic neuropathy (CON) in Graves' disease caused by hypertrophy of levator and superior rectus muscles: A case report.
    Hirokawa T; Mimura M; Tonari M; Sato Y; Fujita Y; Matsuo J; Oku H; Sugasawa J; Ikeda T
    Medicine (Baltimore); 2021 Apr; 100(14):e25062. PubMed ID: 33832074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sight-Threatening Graves' Ophthalmopathy during the Third Trimester of Pregnancy: A Case Report.
    Sakurai K; Inoue T; Niitsuma S; Sato R; Takahashi K; Arihara Z
    Tohoku J Exp Med; 2020 Dec; 252(4):321-327. PubMed ID: 33268601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric thyroid-associated orbitopathy: the Children's Hospital of Philadelphia experience and literature review.
    Goldstein SM; Katowitz WR; Moshang T; Katowitz JA
    Thyroid; 2008 Sep; 18(9):997-9. PubMed ID: 18713025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ophthalmopathy in childhood Graves' disease.
    Chan W; Wong GW; Fan DS; Cheng AC; Lam DS; Ng JS
    Br J Ophthalmol; 2002 Jul; 86(7):740-2. PubMed ID: 12084741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graves' Ophthalmopathy in a Paediatric Population.
    Sadeghi Y; Obéric A; Theintz G; Hamédani M
    Klin Monbl Augenheilkd; 2017 Apr; 234(4):591-594. PubMed ID: 28329893
    [No Abstract]   [Full Text] [Related]  

  • 8. An infant case of Graves' disease with ophthalmopathy.
    Kubo T; Shimizu J; Furujo M; Takeuchi A; Yoshioka-Iwaso H; Eguchi N; Fukuhara S; Koyama T; Kanadani T; Shiraga H; Oshima K
    Endocr J; 2005 Oct; 52(5):647-50. PubMed ID: 16284447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood Graves' ophthalmopathy: results of a European questionnaire study.
    Krassas GE; Segni M; Wiersinga WM
    Eur J Endocrinol; 2005 Oct; 153(4):515-21. PubMed ID: 16189172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graves' ophthalmopathy.
    Yeatts RP
    Med Clin North Am; 1995 Jan; 79(1):195-209. PubMed ID: 7808092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronology of Graves' ophthalmopathy in an incidence cohort.
    Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
    Am J Ophthalmol; 1996 Apr; 121(4):426-34. PubMed ID: 8604736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graves' disease induced by IFN-β1a therapy: A case report, review of literature and new insights into the pathogenesis.
    Patrizio A; Viva T; Ferrari SM; Elia G; Ragusa F; Paparo SR; Antonelli A; Fallahi P
    Autoimmun Rev; 2023 Feb; 22(2):103238. PubMed ID: 36436749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graves' Ophthalmopathy in the Setting of Primary Hypothyroidism.
    Alajmi S; Alshehri S; Ekhzaimy A
    Cureus; 2022 May; 14(5):e24954. PubMed ID: 35706740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.
    Tanda ML; Piantanida E; Liparulo L; Veronesi G; Lai A; Sassi L; Pariani N; Gallo D; Azzolini C; Ferrario M; Bartalena L
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1443-9. PubMed ID: 23408569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital lymphoma masquerading as thyroid ophthalmopathy.
    Boyce PJ
    J Am Optom Assoc; 1998 Oct; 69(10):666-73. PubMed ID: 9805448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pediatric Case of Graves' Hyperthyroidism with Associated Glucose Intolerance Detected by a Urine Glucose Screening Program at School.
    Ikegami T; Yamamoto Y; Goto M; Kawagoe R; Kawada Y; Kusuhara K
    J UOEH; 2018; 40(3):231-236. PubMed ID: 30224619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
    Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ophthalmopathy of Graves' disease.
    Carter JA; Utiger RD
    Annu Rev Med; 1992; 43():487-95. PubMed ID: 1580604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.